SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following the submission of an expanded deep-sea mining permit application under NOAA's newly streamlined regulatory process, signaling a significant step towards commercial recovery. This, coupled with an upcoming Congressional hearing featuring TMC's CEO and recent White House support for expediting critical mineral permits, has fueled strong bullish sentiment among investors who see deep-sea resources as a national security priority, with many discussing significant upside potential and a potential short squeeze.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ is generating significant buzz following its Memorandum of Understanding with the Government of Gujarat to establish a large-scale post-quantum semiconductor center in India, fueling expectations for future growth. Community members are actively discussing the company's critical role in quantum security, comparing it to other leading tech innovators as CEO Carlos Moreira engages with global leaders at Davos on the urgent need for post-quantum solutions. Despite persistent short interest, investors anticipate LAES will be a foundational player in securing the converging worlds of AI and IoT.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is actively trending as Chairman Ryan Cohen significantly increased his personal stake by purchasing an additional one million shares recently, reinforcing his commitment and challenging other CEOs to buy their company's stock. This substantial insider buying, coupled with another director's purchases, is igniting conversations among the community about potential for a renewed short squeeze and the company's long-term value, with many viewing it as a clear signal that the stock's bottom is established. Enthusiastic discussions highlight hopes for increased trading volume and a "round two" of significant price action, putting pressure on short positions amidst sustained retail interest.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals (SXTP) is seeing explosive trading volume after announcing a partnership to expand direct access to its ARAKODA malaria prevention drug for international travelers, coupled with news defining a potential $1.1 billion market for its babesiosis treatment. The low-float stock is drawing significant community attention, with traders discussing short-squeeze potential and chasing momentum amidst high volatility, though some express caution given the company's history of offerings.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid community discussions regarding a potential US government agreement concerning Greenland's mineral rights, which many believe directly benefits CRML's Tanbreez rare earth project. Investors are actively discussing the company's strategic importance in establishing a non-China heavy rare earth supply chain, with a recent business update call providing additional insights into project funding and development plans.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is actively trending as the community anticipates a major hyperscaler tenant announcement for its expansive AI data center campus in West Texas, following a key acquisition and strategic partnership. Investors are intensely discussing the potential for a significant short squeeze and drawing comparisons to established data center infrastructure leaders, fueling strong bullish sentiment.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is generating significant buzz following FDA authorization for the use of its commercially manufactured GP2 drug product in the Phase III FLAMINGO-01 trial, marking a key de-risking milestone for its breast cancer immunotherapy. The community is sharply divided, with bulls pointing to the low float, high short interest, and ongoing insider buying as catalysts for a potential squeeze, while bears highlight a 'sell the news' pattern and anticipate further pullbacks.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as extreme cold weather forecasts are sending natural gas futures soaring, causing significant declines for this inverse leveraged ETF. The highly volatile natural gas market, often called the "widow maker," has many in the community debating whether to buy KOLD on this sharp dip, anticipating a short-term reversal once the cold snap subsides.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant upward momentum following positive five-year follow-up data from its personalized cancer vaccine trial with Merck, demonstrating a notable reduction in melanoma recurrence. This news has ignited strong bullish sentiment within the community, with many highlighting the transformative potential of mRNA technology in oncology and anticipating further growth. The renewed focus on its diverse pipeline beyond initial vaccine developments is largely driving this increased investor interest.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a licensing deal with Pfizer for its Matrix-M adjuvant, a move the community interprets as significant validation for its platform technology. Traders are actively discussing the potential for a substantial short squeeze and anticipating further partnerships, driving conversations around the stock's re-rating and future value given its high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CP
Share Price: $72.10

Contract Selected: Jun 18, 2026 $70 Calls

Buy Zone: $4.98 – $6.15
Target Zone: $9.12 – $11.15
Potential Upside: 73% ROI

Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

Every trade is a home run. Over 96% win rate on all trades for the past two years, over 1,000,000+ total trades. Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute financial advice. Trading involves risk, and past performance is not indicative of future results.

Fxcapta

fxcapta.com

StockTwits Web

Canadian Pacific Railway Ltd


Share Price: $72.10

Contract Selected: Jun 18, 2026 $70 Calls

Buy Zone: $4.98 – $6.15
Target Zone: $9.12 – $11.15
Potential Upside: 73% ROI

Time to Expiration: 202 Days | Updates via 